用修改的参数可以预测甲状腺素治疗中的失败吗?
Yusuf Başkıran1, Kazım Uçkan2, İzzet Çeleğen2
1Istinye University Faculty of Medicine, Istanbul, Turkey. yusufbaskiran1@gmail.com.
Archives of gynecology and obstetrics
|May 7, 2024
概括
新的标记物,β-人类胆管性淋巴激素 (β-hCG) 与白细胞计数 (BW) 和血小板计数 (BP) 相结合,可以预测异胎妊娠患者的手术需要,改善治疗结果.
科学领域:
- 生殖医学 生殖医学
- 妇科瘤学 妇科瘤学
- 临床化学 临床化学
背景情况:
- 宫外怀孕带来很大的风险,需要准确预测治疗反应.
- 目前用于预测子宫外妊娠中甲状腺素治疗成功的方法需要改进.
研究的目的:
- 为了提高单剂量甲状腺素治疗在子宫外怀孕中的成功预测.
- 用新的全血细胞计和β-hCG参数来识别有治疗失败和破裂风险的患者.
主要方法:
- 对233名异胎妊娠患者的回顾性分析.
- 使用ROC曲线分析开发和评估BW (β-hCGxWBC/1000) 和BP (β-hCGx1000/PLT) 标记物.
- 后勤回归用于评估标记物与手术干预的关联.
主要成果:
- 体和血压标志物表现出高的诊断准确性 (AUC分别为0.99和0.94),用于预测手术需要.
- 针对β-hCG (>2139.03),BW (>30.96) 和BP (>10.17) 的特定值与手术干预有显著的相关性.
- 增加的BW和BP水平与需要手术的可能性更高显著相关.
结论:
- 结合β-hCG,BW和BP是识别需要手术的异位妊娠患者的有效预测指标.
- 这些新型标记物可以帮助优化甲状腺素治疗,并可能减少手术干预和住院时间.
更多相关视频
11:24Evaporation-reducing Culture Condition Increases the Reproducibility of Multicellular Spheroid Formation in Microtiter Plates
Published on: March 7, 2017
7.0K
06:07Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
2.6K
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
158
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
158
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Phase II Reactions: Methylation Reactions
180
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
180
